Novel treatments for type 2 diabetes.
نویسنده
چکیده
منابع مشابه
Novel Treatments Target Type-2 Diabetes.
Patients with type-2 diabetes can control their blood glucose levels through diet and exercise, by losing excess weight, and by taking medications, such as first-line metformin. We examine several promising drugs in the type-2 diabetes pipeline.
متن کاملOptimal intelligent control for glucose regulation
This paper introduces a novel control methodology based on fuzzy controller for a glucose-insulin regulatory system of type I diabetes patient. First, in order to incorporate knowledge about patient treatment, a fuzzy logic controller is employed for regulating the gains of the basis Proportional-Integral (PI) as a self-tuning controller. Then, to overcome the key drawback of fuzzy logic contro...
متن کاملApparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy
AIM To explain the subadditive efficacy typically observed with initial combination treatments for type 2 diabetes. METHODS Individual subject data from 1186 patients with type 2 diabetes [mean glycated haemoglobin (HbA1c) = 8.8%] treated with metformin, canagliflozin or canagliflozin + metformin were used. The baseline HbA1c versus ΔHbA1c relationships for monotherapy arms were determined us...
متن کاملAntioxidant and Inhibitory Activities of Enzymes Linked to Type II Diabetes Mellitus: The novel role of Chrysobalanus orbicularis leaf extract
Background: Chrysobalanus orbicularis is commonly used as food, the seeds as a spice for the popular pepper soup, and the leaves are traditionally utilized for managing type II diabetes mellitus (T2DM) in the Niger Delta area of Nigeria. Due to the limited scientific evidence on C. orbicularis, this study investigated its antioxidant and inhibitory properties against major enzymes linked to T2D...
متن کاملEffect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients
Six months administration of bromocriptine mesylate significantly decreased glycated hemoglobin (HbA1c), fasting blood sugar, postprandial blood sugar, and weight of 22 Indian obese patients with type 2 diabetes mellitus with no serious adverse events. Therefore, the novel mechanism of action, efficacy and acceptable safety profile makes this drug an attractive option for treatment of obese typ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The British journal of general practice : the journal of the Royal College of General Practitioners
دوره 61 586 شماره
صفحات -
تاریخ انتشار 2011